Ideas can be owned, to a certain extent. The creative effort involved in the production of a drug formula is every bit as great as the building of a new chair or other tangible asset. Nothing special separates them and law must reflect that. It is a fundamental violation of property rights to steal from drug companies the rights they own to drugs by allowing the production of generic knock-offs.
